Answers are grounded in this paper and cite their sources.
OBJECTIVE: in patients undergoing laparoscopic hysterectomy. METHODS: The study was a multi-center, non-controlled, evaluator-blinded, randomized clinical trial. A total of 91 participants from 3 study sites were randomly assigned to the hyaluronic acid (HA)- hydroxyethyl starch (HES) barrier agent treatment test group (n=49) or the non-treatment control group (n=42). At Visit 3 (8 weeks±5 days), adhesion formation rates and grades were assessed via second-look laparoscopy, and adverse events (AEs) were evaluated. An independent investigator conducted all assessments. RESULTS: At Visit 3, adhesion rates differed significantly between the 2 groups: 73.47% in the test group and 95.24% in the control group (p=0.005). In the intention-to-treat analysis, adhesion grades at Visit 3 were 1.10±0.87 in the treatment group and 1.45±0.74 in the control group, showing a statistically significant difference (p=0.045). Safety analysis revealed no adverse device effects during the follow-up period in either group and no dropouts due to AEs. Additionally, the test and control groups demonstrated no significant differences in other safety parameters, including vital signs, laboratory tests, physical examinations, and electrocardiogram findings. CONCLUSION: HA-HES barrier agent appears to be a potentially effective and safe adhesion barrier for laparoscopic procedures. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04672421.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: